Department of Internal Medicine, University of Michigan Medical School, University of Michigan, North Campus Research Center, 2800 Plymouth Rd, Bldg 16, Room 243, Ann Arbor, MI, USA; Center for Clinical Management and Research, North Campus Research Center, Ann Arbor VA, 2800 Plymouth Rd, Bldg 16, Room 243, Ann Arbor, MI 48109, USA.
University of Michigan Medical School, 1500 E Medical Center Dr, Ann Arbor, MI, USA.
Drug Alcohol Depend. 2021 Apr 1;221:108583. doi: 10.1016/j.drugalcdep.2021.108583. Epub 2021 Feb 13.
Policy evaluations and health system interventions often utilize International Classification of Diseases (ICD) codes of opioid use, dependence, and abuse to identify individuals with opioid use disorder (OUD) and assess receipt of evidence-based treatments. However, ICD codes may not map directly onto the Diagnostic and Statistical Manual of Mental Disorder (DSM-5) OUD criteria. This study investigates the positive predictive value of ICD codes in identifying patients with OUD.
We conducted a clinical chart review on a national sample of 520 Veterans assigned ICD-9 or ICD-10 codes for opioid use, dependence, or abuse from 2012 to 2017. We extracted evidence of DSM-5 OUD criteria and opioid misuse from clinical documentation in the month preceding and three months following initial ICD code listing, and categorized patients into: 1) high likelihood of OUD, 2) limited aberrant opioid use, 3) prescribed opioid use without evidence of aberrant use, and 4) insufficient information. Positive predictive value was calculated as the percentage of individuals with these ICD codes meeting high likelihood of OUD criteria upon chart review.
Only 57.7 % of patients were categorized as high likelihood of OUD; 16.5 % were categorized as limited aberrant opioid use, 18.9 % prescribed opioid use without evidence of aberrant use, and 6.9 % insufficient information.
Patients assigned ICD codes for opioid use, dependence, or abuse often lack documentation of meeting OUD criteria. Many receive long-term opioid therapy for chronic pain without evidence of misuse. Robust methods of identifying individuals with OUD are crucial to improving access to clinically appropriate treatment.
政策评估和卫生系统干预措施经常利用《国际疾病分类》(ICD)的阿片类药物使用、依赖和滥用代码来识别阿片类药物使用障碍(OUD)患者,并评估是否接受循证治疗。然而,ICD 代码可能无法直接映射到《精神障碍诊断与统计手册》(DSM-5)的 OUD 标准。本研究旨在调查 ICD 代码在识别 OUD 患者方面的阳性预测值。
我们对全国范围内的 520 名退伍军人进行了临床病历回顾,这些退伍军人在 2012 年至 2017 年期间被分配了 ICD-9 或 ICD-10 阿片类药物使用、依赖或滥用代码。我们从 ICD 代码列出前一个月和后三个月的临床记录中提取 DSM-5 OUD 标准和阿片类药物滥用的证据,并将患者分为以下几类:1)高度可能患有 OUD,2)有限的异常阿片类药物使用,3)有处方阿片类药物使用但无异常使用证据,4)信息不足。阳性预测值的计算方法是,在病历回顾中,有这些 ICD 代码的患者中符合 OUD 高可能性标准的比例。
只有 57.7%的患者被归类为高度可能患有 OUD;16.5%的患者被归类为有限的异常阿片类药物使用,18.9%的患者有处方阿片类药物使用但无异常使用证据,6.9%的患者信息不足。
被分配 ICD 代码用于阿片类药物使用、依赖或滥用的患者往往缺乏符合 OUD 标准的记录。许多人因慢性疼痛接受长期阿片类药物治疗,但没有滥用的证据。识别 OUD 患者的可靠方法对于改善获得临床适当治疗的机会至关重要。